Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Advantage
Payers
CVS' stock tumbles as MA pressures drag Q1 results
The company posted $1.1 billion in profit for the quarter as well as $88.4 billion in revenue. Both fell short of Wall Street analysts' expectations.
Paige Minemyer
May 1, 2024 12:30pm
CVS scoops up tech-enabled MA broker Hella Health
Apr 30, 2024 4:00pm
Centene offers look at its Medicaid strategy in 2024
Apr 26, 2024 7:26am
Humana pulls back 2025 guidance following MA rate cut
Apr 24, 2024 7:23am
A look at Medicare's Chronic Care Management program
Apr 18, 2024 1:08pm
UnitedHealth: Seasonal pressures on MA utilization eased in Q1
Apr 16, 2024 4:25pm